We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UPB
876
Upstream Bio Inc
UPB
$377M
| $9.33M | 0.01% |
343,791
-524,208
| -60% | -$13M |
|
877
Madison Square Garden
MSGS
$9.46B
| $9.3M | 0.01% |
35,944
+28,231
| +366% | +$6.43M |
|
878
Scorpio Tankers
STNG
$3.8B
| $9.3M | 0.01% |
182,888
+36,340
| +25% | +$2.07M |
|
879
First Horizon
FHN
$12.2B
| $9.28M | 0.01% |
388,460
-7,873
| -2% | -$176K |
|
880
Check Point Software Technologies
CHKP
$14.2B
| $9.28M | 0.01% |
50,012
-46,398
| -48% | -$8.97M |
|
|
EMBJ
881
Embraer S.A. ADS
EMBJ
$11.4B
| $9.28M | 0.01% |
144,143
+122,855
| +577% | +$7.7M |
|
882
Paylocity
PCTY
$6.73B
| $9.24M | 0.01% |
60,584
+59,284
| +4,560% | +$8.82M |
|
883
Avalo Therapeutics
AVTX
$990M
| $9.22M | 0.01% |
507,550
+451,541
| +806% | +$7.62M |
|
884
BWX Technologies
BWXT
$15.8B
| $9.2M | 0.01% |
+53,244
| New | +$9.99M |
|
885
GCM Grosvenor
GCMG
$783M
| $9.2M | 0.01% |
812,403
-85,072
| -9% | -$972K |
|
886
Emergent Biosolutions
EBS
$391M
| $9.19M | 0.01% |
743,455
-168,933
| -19% | -$1.81M |
|
887
XPeng
XPEV
$12.8B
| $9.15M | 0.01% |
451,392
-5,192,867
| -92% | -$113M |
|
888
State Street SPDR S&P Retail ETF
XRT
$450M
| $9.13M | 0.01% |
107,021
+90,521
| +549% | +$7.6M |
|
889
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
| $9.1M | 0.01% |
58,781
+22,953
| +64% | +$3.44M |
|
890
XP
XP
$8.65B
| $9.08M | 0.01% |
554,770
-37,056
| -6% | -$652K |
|
891
Vanguard Health Care ETF
VHT
$18B
| $9.07M | 0.01% |
+31,508
| New | +$8.8M |
|
892
Vertical Aerospace
EVTL
$186M
| $9.07M | 0.01% |
1,701,501
+273,202
| +19% | +$1.38M |
|
893
PUT
JD.com
JD
$40.2B
| $9.06M | 0.01% |
315,700
+315,600
| +315,600% | +$9.87M |
|
894
Mineralys Therapeutics
MLYS
$2.39B
| $9.04M | 0.01% |
+249,130
| New | +$9.99M |
|
895
CONMED
CNMD
$1.29B
| $9.03M | 0.01% |
+222,386
| New | +$9.67M |
|
|
STUB
896
StubHub Holdings
STUB
$3.5B
| $9.02M | 0.01% |
666,979
+546,871
| +455% | +$8.6M |
|
|
TLN
897
Talen Energy Corp
TLN
$17.8B
| $9.01M | 0.01% |
+24,046
| New | +$9.35M |
|
898
Olema Pharmaceuticals
OLMA
$1.03B
| $9.01M | 0.01% |
+360,394
| New | +$6.41M |
|
899
Frontline
FRO
$8.09B
| $8.96M | 0.01% |
410,735
-299,347
| -42% | -$7M |
|
900
PUT
Amazon
AMZN
$2.66T
| $8.93M | 0.01% |
38,700
+20,900
| +117% | +$4.78M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.